natgillin/translations-raw huggingface dataset:
potassium (2-N-[4-(4-chloro-2,5-dimethoxyphenyl)-5-(2-cyclohexylethyl)-1,3-thiazol-2-yl]carbamoyl-5,7-dimethylindolin-1-yl)acetate
kalijev (2-N-[4-(4-kloro-2,5-dimetoksifenil)-5-(2-cikloheksiletil)-1,3-tiazol-2-il]karbamoil-5,7-dimetilindolin-1-il)acetat
(2-amino-1,3-thiazol-4-yl)acetic acid
(2-amino-1,3-tiazol-4-il)ocetna kislina
N-(2-chloro-6-methylphenyl)-2-(6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-ylamino)thiazole-5-carboxamide or dasatanib (proposed INN)
N-(2-kloro-6-metilfenil)-2-(6-[4-(2-hidroksietil)piperazin-1-il]-2-metilpirimidin-4-ilamino)tiazol-5-karboksamid ali dasatanib (predlagan INN)
(4-methyl-2-sulfanyl-1,3-thiazol-5-yl)acetic acid
(4-metil-2-sulfanil-1,3-tiazol-5-il)ocetna kislina
N4-benzoyl-2'-deoxy-5'-O-(4,4'-dimethoxytrityl)cytidine 3'-(2-cyanoethyl diisopropylphosphoramidite)
N4-benzoil-2'-deoksi-5'-O-(4,4’-dimetoksitritil)citidin 3'-(2-cianoetil diizopropilfosforamidit)
2'-bromo-2'-deoxy-5-methyluridine 3',5'-diacetate
2'-bromo-2'-deoksi-5-metiluridin 3',5'-diacetat
diphenylmethyl (2S,5R)-6,6-dibromo-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate 4-oxide
difenilmetil (2S,5R)-6,6-dibromo-3,3-dimetil-7-okso-4-tia-1-azabiciklo[3.2.0]heptan-2-karboksilat 4-oksid
4-amino-5-fluoro-1-[(2R,5S)-5-(hydroxymethyl)-2,5-dihydrofuran-2-yl]pyrimidin-2(1H)-one
4-amino-5-fluoro-1-[(2R,5S)-5-(hidroksimetil)-2,5-dihidrofuran-2-il]pirimidin-2(1H)-on
diphenylmethyl (7R)-7-(2-2-[(tert-butoxycarbonyl)amino]-1,3-thiazol-4-yl-2- [(trityloxy)imino]acetamido)-3-([(1H-1,2,3-triazol-4-yl)sulfanyl]methylsulfanyl)-3,4-didehydrocepham-4-carboxylate
difenilmetil (7R)-7-(2-2-[(terc-butoksikarbonil)amino]-1,3-tiazol-4-il-2- [(tritiloksi)imino]acetamido)-3-([(1H-1,2,3-triazol-4-il)sulfanil]metilsulfanil)-3,4-didehidrocefam-4-karboksilat
(2R,3S)-2-(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy-3-(4-fluorophenyl)morpholine hydrochloride
(2R,3S)-2-(1R)-1-[3,5-bis(trifluorometil)fenil]etoksi-3-(4-fluorofenil)morfolin hidroklorid
N-5-[2-((6S)-2-amino-4-oxo-3,4,5,6,7,8-hexahydropyrido[2,3-d]pyrimidin-6-yl)ethyl]-4-methylthiophene-2-carbonyl-L-glutamic acid
N-5-[2-((6S)-2-amino-4-okso-3,4,5,6,7,8-heksahidropirido[2,3-d]pirimidin-6-il)etil]-4-metiltiofen-2-karbonil-L-glutaminska kislina
3-(1-2-[4-benzoyl-2-(3,4-difluorophenyl)morpholin-2-yl]ethyl-4-phenylpiperidin-4-yl)-1,1-dimethylurea hydrochloride
3-(1-2-[4-benzoil-2-(3,4-difluorofenil)morfolin-2-il]etil-4-fenilpiperidin-4-il)-1,1-dimetilsečnina hidroklorid
methyl N-(butoxycarbonyl)-3-[(5R)-3-(4-cyanophenyl)-4,5-dihydroisoxazol-5-yl]acetamido-L-alaninate
metil N-(butoksikarbonil)-3-[(5R)-3-(4-cianofenil)-4,5-dihidroizoksazol-5-il]acetamido-L-alaninat
2-7-fluoro-2-oxo-4-[2-(4-thieno[3,2-c]pyridin-4-ylpiperazin-1-yl)ethyl]quinolin-1(2H)-ylacetamide
2-7-fluoro-2-okso-4-[2-(4-tieno[3,2-c]piridin-4-ilpiperazin-1-il)etil]kinolin-1(2H)-ilacetamid
(2R,3R,4S)-4-(1,3-benzodioxol-5-yl)-3-(ethoxycarbonyl)-2-(4-methoxyphenyl)pyrrolidinium (2S)-hydroxy(phenyl)acetate
(2R,3R,4S)-4-(1,3-benzodioksol-5-il)-3-(etoksikarbonil)-2-(4-metoksifenil)pirolidin (2S)-hidroksi(fenil)acetat
(5R)-9-chloro-5-ethyl-5-hydroxy-10-methyl-12-[(4-methylpiperidin-1-yl)methyl]-1,4,5,13-tetrahydro-3H,15H-oxepino[3',4':6,7]indolizino[1,2-b]quinoline-3,15-dione hydrochloride
(5R)-9-kloro-5-etil-5-hidroksi-10-metil-12-[(4-metilpiperidin-1-il)metil]-1,4,5,13-tetrahidro-3H,15H-oksepino[3',4':6,7]indolizino[1,2-b]kinolin-3,15-dion hidroklorid
(7R)-7-amino-3-[2-(1,3,4-thiadiazol-2-ylsulfanyl)ethyl]-3,4-didehydrocepham-4-carboxylic acid
(7R)-7-amino-3-[2-(1,3,4-tiadiazol-2-ilsulfanil)etil]-3,4-didehidrocefam-4-karboksilna kislina
(2S)-hydroxy(phenyl)acetic acid — (1S)-3-(dimethylamino)-1-(2-thienyl)propan-1-ol (1:1) (salt)
(2S)-hidroksi(fenil)ocetna kislina – (1S)-3-(dimetilamino)-1-(2-tienil)propan-1-ol (1:1) (sol)
(7R)-7-amino-3,4-didehydrocepham-4-carboxylic acid
(7R)-7-amino-3,4-didehidrocefam-4-karboksilna kislina
(7R)-7-amino-3-[(1H-1,2,3-triazol-4-ylsulfanyl)methyl]-3,4-didehydrocepham-4-carboxylic acid
(7R)-7-amino-3-[(1H-1,2,3-triazol-4-ilsulfanil)metil]-3,4-didehidrocefam-4-karboksilna kislina
2-(2-furyl)-7-(2-4-[4-(2-methoxyethoxy)phenyl]piperazin-1-ylethyl)-7H-pyrazolo[4,3-e][1,2,4]triazolo[2,3-c]pyrimidin-5-amine
2-(2-furil)-7-(2-4-[4-(2-metoksietoksi)fenil]piperazin-1-iletil)-7H-pirazolo[4,3-e][1,2,4]triazolo[2,3-c]pirimidin-5-amin
(2S)-2-methoxy-3-4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]-1-benzothiophen-7-ylpropanoic acid
(2S)-2-metoksi-3-4-[2-(5-metil-2-fenil-1,3-oksazol-4-il)etoksi]-1-benzotiofen-7-ilpropanojska kislina
potassium 4-[N-(2-fluorobenzyl)carbamoyl]-1-methyl-2-[1-methyl-1-(5-methyl-1,3,4-oxadiazole-2-carboxamido)ethyl]-6-oxo-1,6-dihydropyrimidine-5-olate
kalijev 4-[N-(2-fluorobenzil)karbamoil]-1-metil-2-[1-metil-1-(5-metil-1,3,4-oksadiazol-2-karboksamido)etil]-6-okso-1,6-dihidropirimidin-5-olat
(7R)-7-amino-3-chloro-3,4-didehydrocepham-4-carboxylic acid
(7R)-7-amino-3-kloro-3,4-didehidrocefam-4-karboksilna kislina
7-(bromoacetamido)-7-methoxy-3-[(1-methyl-1H-tetrazol-5-yl)lsulfanyl]methyl-3,4-didehydrocepham-4-carboxylic acid
7-(bromoacetamido)-7-metoksi-3-[(1-metil-1H-tetrazol-5-il)lsulfanil]metil-3,4-didehidrocefam-4-karboksilna kislina
4-nitrobenzyl (7R)-7-amino-3-((2S)-tetrahydrofuran-2-yl)-3,4-didehydrocepham-4-carboxylate hydrochloride
4-nitrobenzil (7R)-7-amino-3-((2S)-tetrahidrofuran-2-il)-3,4-didehidrocefam-4-karboksilat hidroklorid
(7R)-7-amino-3-[(1-methyl-1H-tetrazol-5-yl)sulfanyl]methyl-3,4-didehydrocepham-4-carboxylic acid hydrochloride
(7R)-7-amino-3-[(1-metil-1H-tetrazol-5-il)sulfanil]metil-3,4-didehidrocefam-4-karboksilna kislina, hidroklorid
1,4-dithia-7-azaspiro[4.4]nonane-8-carboxylic acid hydrobromide
1,4-ditia-7-azaspiro[4.4]nonan-8-karboksilna kislina, hidrobromid
(3S)-6,6-dibromo-2,2-dimethylpenam-3-carboxylic acid 1,1-dioxide
(3S)-6,6-dibromo-2,2-dimetilpenam-3-karboksilna kislina 1,1-dioksid
(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-13-[(2,6-dideoxy-3-C-methyl-3-O-methyl-α-L-ribo-hexopyranosyl)oxy]-2-ethyl-3,4,10-trihydroxy-3,5,8,10,12,14-hexamethyl-11-[3,4,6-trideoxy-3-(dimethylamino)-β-D-xylo-hexopyranosyl]oxy-1-oxa-6-azacyclopentadecan-15-one
(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-13-[(2,6-dideoksi-3-C-metil-3-O-metil-α-L-ribo-heksopiranozil)oksi]-2-etil-3,4,10-trihidroksi-3,5,8,10,12,14-heksametil-11-[3,4,6-trideoksi-3-(dimetilamino)-β-D-ksilo-heksopiranozil]oksi-1-oksa-6-azaciklopentadekan-15-on
trans-(7R)-7-amino-3-vinyl-3,4-didehydrocepham-4-carboxylic acid
trans-(7R)-7-amino-3-vinil-3,4-didehidrocefam-4-karboksilna kislina
(4S)-4,11-diethyl-4,9-dihydroxy-1H,12H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione
(4S)-4,11-dietil-4,9-dihidroksi-1H,12H-pirano[3',4':6,7]indolizino[1,2-b]kinolin-3,14(4H,12H)-dion
2'-deoxy-5'-O-(4,4'-dimethoxytrityl)-N2-isobutyrylguanosine 3'-(2-cyanoethyl diisopropylphosphoramidite)
2'-deoksi-5'-O-(4,4’-dimetoksitritil)-N2-izobutirilgvanozin 3'-(2-cianoetil diizopropilfosforamidit)
2'-deoxy-5'-O-(4,4'-dimethoxytrityl)thymidine 3'-(2-cyanoethyl diisopropylphosphoramidite)
2'-deoksi-5'-O-(4,4’-dimetoksitritil)timidin 3'-(2-cianoetil diizopropilfosforamidit)
N6-benzoyl-2'-deoxy-5'-O-(4,4'-dimethoxytrityl)adenosine 3'-(2-cyanoethyl diisopropylphosphoramidite)
N6-benzoil-2'-deoksi-5'-O-(4,4’-dimetoksitritil)adenozin 3'-(2-cianoetil diizopropilfosforamidit)
(2S)-2-[(S)-(2-ethoxyphenoxy)phenylmethyl]morpholine
(2S)-2-[(S)-(2-etoksifenoksi)fenilmetil]morfolin
4-[5-(4-fluorophenyl)-3-(trifluoromethyl)pyrazol-1-yl]benzene-1-sulfonamide
4-[5-(4-fluorofenil)-3-(trifluorometil)pirazol-1-il]benzen-1-sulfonamid
N-(3-methoxy-5-methylpyrazin-2-yl)-2-[4-(1,3,4-oxadiazol-2-yl)phenyl]pyridine-3-sulfonamide
N-(3-metoksi-5-metilpirazin-2-il)-2-[4-(1,3,4-oksadiazol-2-il)fenil]piridin-3-sulfonamid
2-ethoxy-5-(4-ethylpiperazine-1-sulfonyl]nicotinic acid
2-etoksi-5-(4-etilpiperazin-1-sulfonil]nikotinska kislina
mixture of sennoside A and B
mešanica senozida A in B
mixture of sennoside A and B, calcium salts
mešanica senozida A in B, kalcijeve soli
(6aR)-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de, g]quinoline-10,11-diol or apomorphine
(6aR)-6-metil-5,6,6a,7-tetrahidro-4H-dibenzo[de, g]kinolin-10,11-diol ali apomorfin
2-[2-methyl-1-(propionyloxy)propoxy]-2-[(4-phenylbutyl)phosphinoyl]acetic acid, (9R)-cinchonan-9-ol salt (1:1)
2-[2-metil-1-(propioniloksi)propoksi]-2-[(4-fenilbutil)fosfinoil]ocetna kislina, (9R)-cinkonan-9-olova sol (1:1)
benzyl 2,6-dimethoxy-4-(5R,5aR,8aR,9S)-6-oxo-9-[(2,3,4,6-tetra-O-benzyl-β-D-glucopyranosyl)oxy]-5,5a,6,8,8a,9-hexahydrofuro[3',4':6,7]naphtho[2,3-d][1,3]dioxol-5-ylphenyl carbonate
benzil 2,6-dimetoksi-4-(5R,5aR,8aR,9S)-6-okso-9-[(2,3,4,6-tetra-O-benzil-β-D-glukopiranozil)oksi]-5,5a,6,8,8a,9-heksahidrofuro[3',4':6,7]nafto[2,3-d][1,3]dioksol-5-ilfenil karbonat
(5S,5aS,9S)-9-(4-hydroxy-3,5-dimethoxyphenyl)-8-oxo-5,5a,6,8,8a,9-hexahydrofuro[3',4':6,7]naphtho[2,3-d][1,3]dioxol-5-yl 2,3-di-O-benzyl-4,6-O-[(1R)-ethylidene]-β-D-glucopyranoside
(5S,5aS,9S)-9-(4-hidroksi-3,5-dimetoksifenil)-8-okso-5,5a,6,8,8a,9-heksahidrofuro[3',4':6,7]nafto[2,3-d][1,3]dioksol-5-il 2,3-di-O-benzil-4,6-O-[(1R)-etiliden]-β-D-glukopiranozid
(2S,3S,4R,5R)-2-(hydroxymethyl)piperidine-3,4,5-triol
(2S,3S,4R,5R)-2-(hidroksimetil)piperidin-3,4,5-triol
dicyclohexylammmonium (7R)-3-(acetoxymethyl)-7-[2-((3R)-3-[(tert-butoxycarbonyl)amino]-3-carboxypropylamino)-2-oxoethyl]-3,4-didehydrocepham-4-carboxylate or cephalosporin D dicyclohexylamine salt
diciklohekzilamonij (7R)-3-(acetoksimetil)-7-[2-((3R)-3-[(terc-butoksikarbonil)amino]-3-karboksipropilamino)-2-oksoetil]-3,4-didehidrocefam-4-karboksilat ali cefalosporin D dicikloheksilaminova sol
(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethan-1-ol, acetonitrile solution
(1R)-1-[3,5-bis(trifluorometil)fenil]etan-1-ol, acetonitrilova raztopina
(3S)-3-[2-(mesyloxy)ethoxy]-4-(trityloxy)butyl methanesulfonate, dimethylformamide solution
(3S)-3-[2-(meziloksi)etoksi]-4-(tritiloksi)butil metansulfonat, dimetilformamidova raztopina
4-(4-chloro-1,2,5-thiadiazol-3-yl)morpholine, toluene solution
4-(4-kloro-1,2,5-tiadiazol-3-il)morfolin, toluenova raztopina
(2S,3R)-4-(dimethylamino)-3-methyl-1,2-diphenylbutan-2-ol, toluene solution
(2S,3R)-4-(dimetilamino)-3-metil-1,2-difenilbutan-2-ol, toluenova raztopina
4-[2-(piperidin-1-yl)ethoxy]benzoyl chloride hydrochloride, 1,2-dichloroethane solution
4-[2-(piperidin-1-il)etoksi]benzoil klorid hidroklorid, 1,2-dikloroetanova raztopina
List of pharmaceutical intermediates, i.e. compounds used for the manufacture of finished pharmaceutical products, to be withdrawn from the list of products receiving duty-free treatment included in Annex 6 to Regulation (EC) No 1549/2006
Seznam farmacevtskih vmesnih produktov, t. j. spojin, ki se uporabljajo za proizvodnjo končnih farmacevtskih izdelkov, ki jih je treba umakniti s seznama dajatev prostih izdelkov iz Priloge 6 k Uredbi (ES) št. 1549/2006 Identifikacijska številka
isopropyl (Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-(E)-(3R)-3-hydroxy-4-[3-(trifluoromethyl)phenoxy]but-1-enylcyclopentyl]hept-5-enoate
izopropil(Z)-7-[(1R,2R,3R,5S)-3,5-dihidroksi-2-(E)-(3R)-3-hidroksi-4-[3-(trifluorometil)fenoksi]but-1-enilciklopentil] hept-5-enoat
N-[(2,6-diisopropylphenoxy)sulfonyl]-2-(2,4,6-triisopropylphenyl)acetamide
N-[(2,6-diizopropilfenoksi)sulfonil]-2-(2,4,6-triizopropilfenil)acetamid
avasimibe (INN)
avasimib (INN)
13-ethyl-17-alpha-hydroxy-18,19-dinorpregn-4-en-20-yn-3-one oxime
13-etil-17-alfa-hidroksi-18,19-dinorpregn-4-en-20-in-3-on oksim
2-hydroxy-4-(methylthio)butyric acid
2-hidroksi-4-(metiltio)maslena kislina
methyl O-2-deoxy-6-O-sulfo-2-(sulfoamino)-alpha-D-glucopyranosyl-(1,4)-O-beta-D-glucopyranuronosyl-(1,4)-O-2-deoxy-3,6-di-O-sulfo-2-(sulfoamino)-alpha-D-glucopyranosyl-(1,4)-O-2-O-sulfo-alpha-L-idopyranuronosyl-(1,4)-2-deoxy-2-(sulfoamino)-6-(hydrogen sulfate)-alpha-D-glucopyranoside, decasodium salt
metil O-2-deoksi-6-O-sulfo-2-(sulfoamino)-alfa-D-glukopiranozil-(1,4)-O-beta-D-glukopiranuronozil- (l,4)-O-2-deoksi-3,6-di-O-sulfo-2-(sulfoamino)-alfa-D-glukopiranozil-(1,4)-O-2-O-sulfo-alfa- L-idopiranuronozil-(l,4)-2-deoksi-2-(sulfoamino)-6-(hidrogen sulfat)-alfa-D-glukopiranozid, dekanatrijeva sol
fondaparinux sodium (INN)
natrijev fondaparinuks (INN)
[1-(4-fluorobenzyl)-1H-benzimidazol-2-yl](4-piperidyl)amine
[1-(4-fluorobenzil)-1H-benzimidazol-2-il](4-piperidil)amin
tecastemizole (INN)
tekastemizol (INN)
8-chloro-11-(4-piperidylidene)-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridine
8-kloro-11-(4-piperidiliden)-5,6-dihidro-11H-benzo[5,6]ciklohepta[1,2-b]piridin
desloratadine (INN)
desloratadin (INN)
5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-N-piperidino-1H-pyrazole-3-carboxamide
5-(4-klorofenil)-1-(2,4-diklorofenil)-4-metil-N-piperidino-1H-pirazol-3-karboksamid
4-4-[(11R)-3,10-dibromo-8-chloro-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-yl]piperidinocarbonylmethylpiperidine-1-carboxamide
4-4-[(11R)-3,10-dibromo-8-kloro-5,6-dihidro-11H-benzo[5,6]ciklohepta[1,2-b]piridin-11-il] piperidinokarbonilmetilpiperidin-1-karboksamid
2-[1-(7-chloro-4-quinolyl)-5-(2,6-dimethoxyphenyl)-1H-pyrazol-3-yl]carbonylaminoadamantane-2-carboxylic acid
2-[1-(7-kloro-4-kinolil)-5-(2,6-dimetoksifenil)-1H-pirazol-3-il]karbonilaminoadamantan-2-karboksilna kislina
(R)-[2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methylphosphonic acid
(R)-[2-(6-amino-9H-purin-9-il)-1-metiletoksi]metilfosfonska kislina
6-benzyl-1-(ethoxymethyl)-5-isopropylpyrimidine-2,4(1H,3H)-dione
6-benzil-1-(etoksimetil)-5-izopropilpirimidin-2,4(1H,3H)-dion
(S)-2-(4-[(2,7-dimethyl-4-oxo-1,4-dihydroquinazolin-6-yl)methyl](prop-2-ynyl)amino-2-fluorobenzamido)-4-(1H-tetrazol-5-yl)butyric acid
(S)-2-(4-[(2,7-dimetil-4-okso-1,4-dihidrokinazolin-6-il)metil](prop-2-inil)amino-2-fluorobenzamido)-4-(1H-tetrazol-5-il)maslena kislina
(+-)-6-fluoro-1-methyl-4-oxo-7-(piperazin-1-yl)-4H-[1,3]thiazeto[3,2-a]quinoline-3-carboxylic acid
(+-)-6-fluoro-1-metil-4-okso-7-(piperazin-1-il)-4H-[1,3]tiazeto[3,2-a]kinolin-3-karboksilna kislina
(2R,4R)-4-(2,6-diamino-9H-purin-9-yl)-1,3-dioxolan-2-ylmethanol
(2R,4R)-4-(2,6-diamo-9H-purin-9-il)-1,3-dioksolan-2-ilmetanol
4-[4-(4-4-[(3R,5R)-5-(2,4-difluorophenyl)-5-(1H-1,2,4-triazol-1-ylmethyl)tetrahydrofuran-3-ylmethyloxy]phenylpiperazin-1-yl)phenyl]-1-[(1S,2S)-1-ethyl-2-hydroxypropyl]-1,2,4-triazol-5(4H)-one
4-[4-(4-4-[(3R,5R)-5-(2,4-difluorofenil)-5-(1H-1,2,4-triazol-1-ilmetil)tetrahidrofuran-3-ilmetiloksi]fenilpiperazin-1-il)fenil]-1-[(1S,2S)-1-etil-2-hidroksipropil]-1,2,4-triazol-5(4H)-on
(3-chloro-4-fluorophenyl)[7-methoxy-6-(3-morpholinopropoxy)quinazolin-4-yl]amine
(3-kloro-4-fluorofenil)[7-metoksi-6-(3-morfolinopropoksi)kinazolin-4-il]amin
N'-(2R,3S)-5-chloro-3-(2-chlorophenyl)-1-[(3,4-dimethoxyphenyl)sulfonyl]-3-hydroxy-2,3-dihydro-1H-indol-2-ylcarbonyl-L-prolinamide
N'-(2R,3S)-5-kloro-3-(2-klorofenil)-1-[(3,4-dimetoksifenil)sulfonil]-3-hidroksi-2,3-dihidro-1H-indol- 2-ilkarbonil-L-prolinamid
(3S)-tetrahydrofuran-3-yl (1S,2R)-3-[(4-aminophenylsulfonyl)(isobutyl)amino]-1-benzyl-2-hydroxypropylcarbamate
(3S)-tetrahidrofuran-3-il (1S,2R)-3-[(4-aminofenilsulfonil)(izobutil)amino]-1-benzil-2-hidroksipropilkarbamat
4-[5-(p-tolyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide
4-[5-(p-tolil)-3-(trifluorometil)-1H-pirazol-1-il]benzensulfonamid
celecoxib (INN)
celekoksib (INN)
4-(4-cyclohexyl-2-methyloxazol-5-yl)-2-fluorobenzenesulfonamide
4-(4-cikloheksil-2-metiloksazol-5-il)-2-fluorobenzensulfonamid
tilmacoxib (INN)
tilmakoksib (INN)
4-(5-methyl-3-phenylisoxazol-4-yl)benzenesulfonamide
4-(5-metil-3-fenilizoksazol-4-il)benzensulfonamid
valdecoxib (INN)
valdekoksib (INN)
(S)-N-hydroxy-2,2-dimethyl-4-[4-(4-pyridyloxy)phenylsulfonyl]-1,4-thiazinane-3-carboxamide
(S)-N-hidroksi-2,2-dimetil-4-[4-(4-piridiloksi)fenilsulfonil]-1,4-tiazinan-3-karboksamid
antithrombin alfa
antithombin alfa
(2E)-but-2-enedioyl (INNCN)
(2E)-but-2-enedioil (INNCN)
sulphite 424a
sulfit
ID No
Oznaka KN
plevitrexed (INN)
plevitreksed (INN)
ulifloxacin (INN)
ulifloksacin (INN)
midostaurin
midostavrin
ruboxistaurin
ruboksistavrin
adargileukin alfa
adargilevkin alfa
(acetyloxy)methyl (INNCN)
(acetiloksi)metil (INNCN)
axetil (INNRG)
aksetil (INNRG)
rac-1-(acetyloxy)ethyl (INNCN)
rac-1-(acetiloksi)etil (INNCN)
(benzoyloxy)methyl (INNCN)
(benzoiloksi)metil (INNCN)
cituxetan (INNRG)
cituksetan (INNRG)
(5-methyl-2-oxo-1,3-dioxol-4-yl)methyl (INNCN)
(5-metil-2-okso-1,3-dioksol-4-il)metil (INNCN)
1-deoxy-1-methylamino-D-glucitol
1-deoksi-1-metilamino-D-glucitol
(RS)-1-[(2,2-dimethylpropanoyl)oxy]ethyl (INNCN)
(RS)-1-[(2,2-dimetilpropanoil)oksi]etil (INNCN)
proxetil (INNRG)
proksetil (INNRG)
rac-2-(decyloxy)-3-(dodecylsulfanyl)propyl (INNCN)
rac-2-(deciloksi)-3-(dodecilsulfanil)propil (INNCN)
CAS RN
Številka CAS
amdoxovir (INN)
amdoksovir (INN)
besilate (INNRG) besylate
bezilat (INNRG)
ciclotate (INNRG) cyclotate
ciklotat (INNRG)
enanthate heptanoate (INNCN)
heptanoat (INNCN)
etilsulfate (INNRG) ethylsulfate
etilsulfat (INNRG)
hibenzate (INNRG) hybenzate
hibenzat (INNRG)
lauril (INNRG) lauryl
lavril (INNRG)
4-aminosalicylate aminosalicylate
4-aminosalicilat
metiodide (INNRG) methyliodide
metiljodid (INNRG)
CN code CAS RN
Številka CAS
Commission Regulation (EC) No 130/2007
Uredba Komisije (ES) št. 130/2007
of 13 February 2007
z dne 13. februarja 2007
This Regulation shall enter into force on 14 February 2007.
Ta uredba začne veljati 14. februarja 2007.
Done at Brussels, 13 February 2007.
V Bruslju, 13. februarja 2007
to Commission Regulation of 13 February 2007 establishing the standard import values for determining the entry price of certain fruit and vegetables
k Uredbi Komisije z dne 13. februarja 2007 o določitvi pavšalnih uvoznih vrednosti za določanje vhodne cene nekaterega sadja in zelenjave
Commission Regulation (EC) No 131/2007
Uredba Komisije (ES) št. 131/2007
amending Regulation (EC) No 990/2006 as regards the quantities covered by standing invitations to tender for the export of common wheat and barley held by the intervention agencies of certain Member States
o spremembi Uredbe (ES) št. 990/2006 kar zadeva količine, ki jih zajemajo stalni javni razpisi za izvoz navadne pšenice in ječmena iz zalog intervencijskih agencij nekaterih držav članic
Commission Regulation (EC) No 990/2006 [2] opened standing invitations to tender for the export of cereals held by the intervention agencies of the Member States.
Z Uredbo Komisije (ES) št. 990/2006 [2] so odprti stalni javni razpisi za izvoz žit iz zalog intervencijskih agencij držav članic.
Economic operators have not submitted tenders for some of the cereals covered by these tenders for several weeks now, apart from recent bids for small quantities. This is due in particular to the more favourable conditions for resale on the internal market under Commission Regulation (EC) No 1483/2006 of 6 October 2006 opening standing invitations to tender for the resale on the Community market of cereals held by the intervention agencies of the Member States [3].
Za nekatera žita iz javnih razpisov gospodarski subjekti že več tednov niso vložili ponudb, razen nedavnih ponudb za majhne količine, zlasti zaradi pogojev ugodnejše ponovne prodaje na notranjem trgu v okviru Uredbe Komisije (ES) št. 1483/2006 z dne 6. oktobra 2006 o odprtju stalnega javnega razpisa za ponovno prodajo žit iz zalog intervencijskih agencij držav članic na trgu Skupnosti [3].
Resale on the internal market has increased sharply over that period.
Ponovna prodaja na notranjem trgu se je v navedenem obdobju močno povečala.
In view of this situation and in order to make the quantities of common wheat and barley currently blocked in respect of the standing invitations to tender under Regulation (EC) No 990/2006 available for resale on the internal market, the quantities covered by those invitations to tender should be reduced, in the case of common wheat, by 968 tonnes for the Czech Republic, 199946 tonnes for Hungary and 91 tonnes for Slovakia, and, in the case of barley, by 342 tonnes for Lithuania, 19011 tonnes for Hungary and 356 tonnes for Poland.
Ob upoštevanju tega stanja in da bi količine navadne pšenice in ječmena, ki so zdaj blokirane v skladu s stalnimi javnimi razpisi v okviru Uredbe (ES) št. 990/2006, sprostili v vnovično prodajo na notranjem trgu, je treba zmanjšati količine, zajete z navedenimi javnimi razpisi, za 968 ton za Republiko Češko, 199946 ton za Madžarsko in 91 ton za Slovaško za navadno pšenico in za 342 ton za Litvo, 19011 ton za Madžarsko in 356 ton za Poljsko za ječmen.
Regulation (EC) No 990/2006 should therefore be amended accordingly.
Uredbo (ES) št. 990/2006 je zato treba ustrezno spremeniti.
Annex I to Regulation (EC) No 990/2006 is hereby replaced by the text in the Annex to this Regulation.
Priloga I k Uredbi (ES) št. 990/2006 se nadomesti z besedilom iz Priloge k tej uredbi.
Regulation as last amended by Regulation (EC) No 37/2007 (OJ L 11, 18.1.2007, p. 3).
Uredba, kakor je bila nazadnje spremenjena z Uredbo (ES) št. 37/2007 (UL L 11, 18.1.2007, str. 3).
Regulation as last amended by Regulation (EC) No 91/2007 (OJ L 22, 31.1.2007, p. 5).
Uredba, kakor je bila nazadnje spremenjena z Uredbo (ES) št. 91/2007 (UL L 22, 31.1.2007, str. 5).
Name, address and contact details
Naziv, naslov in drugi podatki
Commission Regulation (EC) No 132/2007
Uredba Komisije (ES) št. 132/2007
In view of the situation on the Community markets for common wheat and barley and of the changes in demand for cereals in various regions in recent weeks, new quantities of cereals held in intervention should be made available in some Member States.
Zaradi stanja na trgih navadne pšenice in ječmena v Skupnosti ter sprememb v povpraševanju po žitih, ki so bile v zadnjih tednih ugotovljene v različnih regijah, je treba v nekaterih državah članicah dati na razpolago nove količine žit iz intervencijskih zalog.
The intervention agencies in the Member States concerned should therefore be authorised to increase the quantities put out to tender by 598269 tonnes of common wheat in Germany and by 100000 tonnes of common wheat and 19011 tonnes of barley in Hungary.
Zato je treba intervencijskim agencijam zadevnih držav članic dovoliti povečanje količin v javnem razpisu do količine 598269 ton v Nemčiji in 100000 ton na Madžarskem za navadno pšenico, in 19011 ton na Madžarskem za ječmen.
Commission Regulation (EC) No 133/2007
Uredba Komisije (ES) št. 133/2007
setting the allocation coefficient for issuing of licences applied for from 5 to 9 February 2007 to import sugar products under tariff quotas and preferential agreements
o določitvi koeficienta dodelitve za izdajo uvoznih dovoljenj, za katera je bilo zaprošeno od 5. do 9. februarja 2007, za proizvode iz sladkorja v okviru tarifnih kvot in preferencialnih sporazumov
Applications for import licences were submitted to the competent authority during the week of 5 to 9 February 2007, in accordance with Regulation (EC) No 950/2006 or Commission Regulation (EC) No 1832/2006 of 13 December 2006 laying down transitional measures in the sugar sector by reason of the accession of Bulgaria and Romania [3] for a total quantity equal to or exceeding the quantity available for serial number 09.4347.
Zahtevki za uvozna dovoljenja so bili pristojnim organom predloženi v tednu od 5. do 9. februarja 2007 v skladu z Uredbo (ES) št. 950/2006 ali Uredbo Komisije (ES) št. 1832/2006 z dne 13. decembra 2006 o prehodnih ukrepih v sektorju sladkorja zaradi pristopa Bolgarije in Romunije [3] za skupno količino, ki je enaka ali presega razpoložljivo količino za zaporedno številko 09.4347.
Licences shall be issued within the quantitative limits set in the Annex to this Regulation in respect of applications for import licences submitted from 5 to 9 February 2007, in accordance with Article 4(2) of Regulation (EC) No 950/2006 or Article 5 of Regulation (EC) No 1832/2006.
Za zahtevke za uvozna dovoljenja, predložene od 5. do 9. februarja 2007 v skladu s členom 4(2) Uredbe (ES) št. 950/2006 ali v skladu s členom 5 Uredbe (ES) št. 1832/2006, se dovoljenja izdajo v okviru količin, ki so navedene v Prilogi k tej uredbi.
Week of 5 to 9 February 2007: % of requested quantity to be granted
% zahtevanih količin za izdajo za teden od 5. do 9. februarja 2007
Commission Regulation (EC) No 134/2007
Uredba Komisije (ES) št. 134/2007
This Regulation shall enter into force on 22 February 2007.
Ta uredba začne veljati 22. februarja 2007.